Modificaciones en los ttulos de anticuerpos antipptidos cclicos citrulinados (ANTI CCP) con el uso de agentes antifactor de necrosis tumoral alfa (ANTI TNF) en pacientes con artritis reumatoide
Texto completo
Figure
Documento similar
Los objetivos de este estudio son: 1.- Conocer la res- puesta a etanercept biosimilar (E-BS) en pacientes naive diagnosticados de artritis reumatoide, artritis psoriásica y
No se observaron diferencias en la mediana de la variable IDT entre los pacientes incluidos en el registro durante los 5 primeros años respecto a los
Therefore, we performed a candidate gene study to investigate single-nucleotide polymorphisms (SNPs) that can predict the response to anti-TNF drugs in Caucasian
Through looking at the link between the chemical structure and the activity, our study proves that changes made to natural macamides at the level of the alkyl chain, the
Circulating interleukin 6 and albumin, and infliximab levels are good predictors of recovering efficacy after dose escalation infliximab therapy in patients with loss of response
The analysis of low-frequency genetic variants mapping to the TNF signaling pathway using the SKAT-O test showed that the damaging burden is different between anti-TNF
a The serological component of the 2010 ACR/EULAR RA classification criteria, the concordance (Ccdc.) of RF, anti-CCP and anti-AcOrn autoantibodies, and their combination (2010
Therefore, we aimed to evaluate the potential of the concordant presence of RF, anti-CCP and anti-carbamylated protein antibodies to improve current RA classification among
